MediXall Group, Inc.
MDXL · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $75 | $109 | $83 |
| - Cash | $0 | $0 | $0 | $1 |
| + Debt | $4 | $3 | $0 | $0 |
| Enterprise Value | $4 | $77 | $110 | $83 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 422.1% | 295.3% | – | – |
| Gross Profit | $0 | -$3 | -$3 | -$3 |
| % Margin | 23.6% | -5,296.2% | -20,349.5% | – |
| EBITDA | -$4 | -$7 | -$6 | -$6 |
| % Margin | -1,254.6% | -11,006.9% | -40,835.9% | – |
| Net Income | -$5 | -$7 | -$6 | -$6 |
| % Margin | -1,474.8% | -11,524.6% | -40,245.8% | – |
| EPS Diluted | -0.037 | -0.061 | -0.058 | -0.066 |
| % Growth | 38.9% | -5.7% | 11.6% | – |
| Operating Cash Flow | -$1 | -$4 | -$5 | -$4 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$1 | -$4 | -$5 | -$4 |